XT
CAPR icon

XTX Topco’s Capricor Therapeutics CAPR Stock Holding History

XTX Topco’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Buy
+21,993
New +$667K 0.01% 2402
2025
Q4 		– Sell
-14,442
Closed -$104K – 3356
2025
Q3 		$104K Sell
14,442
-13,057
-47% -$96.1K 0.01% 2016
2025
Q2 		$273K Sell
27,499
-27,371
-50% -$289K 0.01% 1505
2025
Q1 		$521K Buy
+54,870
New +$762K 0.03% 1002

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

XTX Topco's CAPR Position: Q2 2026 in Review

XTX Topco opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 21,993 shares worth $530K. The stake represents 0.01% of the portfolio and ranks #2402 among its holdings. This is a return to the name: XTX Topco previously reported a position in CAPR as recently as Q3 2025.

XTX Topco first reported a position in CAPR in Q1 2025 and has held it in 4 quarters since. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • XTX Topco held 21,993 shares of Capricor Therapeutics worth $530K as of Q2 2026.
  • Capricor Therapeutics was a new XTX Topco position in Q2 2026.
  • Capricor Therapeutics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2402 holding.
  • XTX Topco first reported a position in Capricor Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.